Abstract
The aim – to evaluate the clinical outcomes of surgical treatment in patients with combined aortic and mitral valve disease in the setting of concomitant coronary artery disease (CAD), who underwent simultaneous valve replacement and coronary artery bypass grafting (CABG), with analysis of preoperative, intraoperative, and postoperative parameters. Materials and methods. A retrospective analysis of 35 cases of combined surgical interventions (AVR + MVR + CABG), performed at the Heart Institute of the Ministry of Health of Ukraine between 2019 and 2023, was conducted. The study assessed clinical characteristics, echocardiographic findings, intraoperative data, postoperative course, complications, and mortality rates. Risk stratification was performed using EuroSCORE II and the STS Risk Calculator.Results. In patients with severe multivalvular disease (n = 35), mitral regurgitation (100 %) and concomitant heart failure (94.3 %) were predominant. Postoperative improvement of NYHA class was observed in 74.3 % of cases. Mortality rate was 14.3 %, with infectious (51 %) and neurological (39 %) complications being common. Atrial fibrillation was associated with higher mortality. Postoperative echocardiography showed improved hemodynamics. These findings confirm the effectiveness of combined surgical intervention when careful patient selection is ensured.Conclusions. Simultaneous aortic and mitral valve replacement combined with coronary artery bypass grafting (CABG) represents a clinically justified surgical strategy for patients with combined valvular pathology and coronary artery disease, including those at intermediate and high risk according to the EuroSCORE II and STS scales. Despite acceptable survival rates, the incidence of postoperative complications remains significant, due to acute kidney injury, stroke, infections, ventricular fibrillation, and the need for reinterventions).

This publication has 15 references indexed in Scilit: